- Home
- MLR vs AVIR Comparison
MLR vs AVIR Comparison
Compare MLR & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLR | AVIR |
|---|---|---|
| Founded | 1990 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 496.6M | 450.9M |
| IPO Year | 2004 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MLR | AVIR |
|---|---|---|
| Price | $47.96 | $5.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $48.50 | $10.00 |
| AVG Volume (30 Days) | 84.4K | ★ 262.4K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.80% | N/A |
| EPS Growth | N/A | ★ 3.00 |
| EPS | ★ 1.98 | N/A |
| Revenue | ★ $790,271,000.00 | $351,367,000.00 |
| Revenue This Year | $10.63 | N/A |
| Revenue Next Year | $18.84 | N/A |
| P/E Ratio | $24.17 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $33.81 | $2.46 |
| 52 Week High | $49.23 | $6.45 |
Technical Indicators
Market Signals| Indicator | MLR | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 56.06 | 50.29 |
| Support Level | $45.95 | $3.28 |
| Resistance Level | $49.09 | $6.37 |
| Average True Range (ATR) | 1.41 | 0.22 |
| MACD | -0.12 | -0.04 |
| Stochastic Oscillator | 63.26 | 48.65 |
Price Performance
Historical ComparisonAbout MLR Miller Industries Inc.
Miller Industries Inc is a manufacturer of Towing and Recovery Equipment. The company designs and manufactures bodies of car carriers and wreckers, which are installed on chassis manufactured by third parties, and sold to customers. Its product lines include car carriers, light duty, heavy duty, rotators, special transport, military, wreckers, and transport trailers. It sells products under various brands including Century, Vulcan, Chevron, Holmes, Challenger, Champion, Jige, Boniface, Omars, Titan, and Eagle.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.